1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Dec 5, 2025 accepted 10:00 PM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Mar 1, 2022 accepted 1:50 AM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Feb 17, 2022 accepted 10:14 PM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jul 25, 2011 accepted 2:43 PM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jan 14, 2011 accepted 9:19 PM ET | PMCBPharmaCyte Biotech, Inc. | 8-K/A 3.01Delisting notice4.02Non-reliance (restatement) | DocumentSEC ↗ |
Sep 15, 2010 accepted 6:46 PM ET | PMCBPharmaCyte Biotech, Inc. | 3.01Delisting notice4.02Non-reliance (restatement) | DocumentSEC ↗ |